(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VASCULAR ADVANTAGE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VASCULAR ADVANTAGE

ST13

US500000078556843

Class

5

Filing

78556843

Registration

3108932

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

08/03/2026

Trademark type

Word

Nice classes

5

Filing date

01/31/2005

Registration date

06/27/2006

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/03/2026

Last transaction

08/03/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

12/01/2004

First use in commerce

12/01/2004

Drawing code

4

Owner type

03

Owner location

Plymouth, MN, US

Examiner

STIGLITZ, SUSAN R

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ENIVA USA, INC.
E. C. (pessoa física)

Representatives

ENIVA USA, INC.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Mineral dietary supplements and nutritional dietary supplements

Publications

History of USPTO decisions and trademark events.

40 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/03/2026

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

08/03/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/03/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/03/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

06/02/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/27/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/16/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/16/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/16/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/16/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/24/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

06/24/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/27/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/13/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/13/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/13/2012

E815

TEAS SECTION 8 & 15 RECEIVED

06/05/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/05/2012

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/18/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

06/27/2006

PUBO

PUBLISHED FOR OPPOSITION

04/04/2006

NPUB

NOTICE OF PUBLICATION

03/15/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/15/2006

ALIE

ASSIGNED TO LIE

02/10/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/30/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

01/30/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/26/2006

FAXX

FAX RECEIVED

01/26/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

01/20/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/09/2006

MAIL

PAPER RECEIVED

01/09/2006

GNRT

NON-FINAL ACTION E-MAILED

12/29/2005

CNRT

NON-FINAL ACTION WRITTEN

12/29/2005

ACEC

AMENDMENT FROM APPLICANT ENTERED

12/23/2005

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/30/2005

MAIL

PAPER RECEIVED

11/30/2005

GNRT

NON-FINAL ACTION E-MAILED

09/02/2005

CNRT

NON-FINAL ACTION WRITTEN

09/02/2005

DOCK

ASSIGNED TO EXAMINER

08/29/2005

NWAP

NEW APPLICATION ENTERED

02/08/2005

Continuous trademark protection

Get notified about every new filing that threatens VASCULAR ADVANTAGE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.